Last updated: May 27, 2026
Nascobal (nasal calcitonin) Suppliers: Who Manufactures, Supplies, and Feeds the Supply Chain
Nascobal’s US supply chain is anchored by the listed marketing authorization holder(s) and the physical manufacturers behind the finished dosage form and key intermediates. The most actionable way to identify “suppliers” in pharma is to map (1) the FDA-listed drug product manufacturer on the label and in the FDA drug application data, (2) contract manufacturing organizations (CMOs) for the nasal spray dosage form, and (3) suppliers of active pharmaceutical ingredient (API) and critical excipients used in the formulation.
No supplier mapping can be produced accurately from the prompt alone.
Which companies are listed as Nascobal drug product manufacturers in the FDA drug record?
No answer can be generated without FDA label and drug application manufacturer data for Nascobal.
What does the Nascobal label say about the manufacturer and distributor?
No answer can be generated without the Nascobal US prescribing information label text.
Does Nascobal have multiple finished-dose sites listed across lots or label revisions?
No answer can be generated without the manufacturer-of-record history.
Who supplies Nascobal API (calcitonin) and where is it manufactured?
No answer can be generated without API vendor or manufacturing site data from the underlying application, inspections, or supplier disclosures.
Is Nascobal API sourced from a single supplier or multiple API makers?
No answer can be generated without procurement or application-level documentation.
What CMOs manufacture the Nascobal nasal spray dosage form?
No answer can be generated without CMO/site attribution from FDA records, label manufacturing addresses, or regulatory filings.
Are there contract manufacturing changes that affect supply continuity?
No answer can be generated without revision-by-revision manufacturing site records.
What excipient suppliers matter for Nascobal nasal spray supply?
No answer can be generated without the excipient list tied to sourcing and functional grade.
Does Nascobal depend on any specialty components with constrained supply?
No answer can be generated without component supplier or quality history.
How does Nascobal’s supply chain affect generic or biosimilar entry risk?
No answer can be generated without exclusivity status, ANDA activity, and whether supply constraints drive differentiation.
What is the Orange Book status of Nascobal and who is authorized to manufacture?
No answer can be generated without Orange Book listing details tied to the active ingredient and dosage form.
What patent-litigation history affects Nascobal manufacturing partners?
No answer can be generated without Nascobal patent estate and litigation dockets that name manufacturers or challengers.
When does Nascobal lose exclusivity and does that change supplier lists?
No answer can be generated without exclusivity and expiration dates.
Key Takeaways
- Supplier identification for Nascobal requires FDA label and drug-record manufacturer-of-record data plus application-level manufacturing site information.
- The prompt does not provide the required FDA/product record inputs to produce a correct supplier roster.
FAQs
- Who is the marketing authorization holder for Nascobal in the US?
- What manufacturing sites are listed on the Nascobal label for the nasal spray?
- Which companies supply calcitonin API used in Nascobal?
- Are there known CMO changes that impact Nascobal availability?
- Do supplier shifts correlate with Orange Book updates for Nascobal?
References
- No sources cited because no Nascobal-specific FDA label or application data was provided in the prompt.
